China Fineblanking Technology Co.,Ltd. carries a market capitalization of 2.00B, placing it among publicly traded companies globally. Its enterprise value stands at 3.07B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.00B |
| Enterprise Value | 3.07B |
China Fineblanking Technology Co.,Ltd. currently has 101.30M shares outstanding.
| Shares Outstanding | 101.30M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 1.10, and the price-to-book ratio stands at 1.85.
| PE Ratio | N/A |
| PS Ratio | 1.10 |
| PB Ratio | 1.85 |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | 8.40 |
| P/OCF Ratio | 10.07 |
| EV / Sales | 1.34 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 9.58 |
China Fineblanking Technology Co.,Ltd. maintains a current ratio of 1.48, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 51.77, indicating elevated leverage, while an interest coverage ratio of -2.82 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.48 |
| Quick Ratio | 0.37 |
| Debt / Equity | 51.77 |
| Debt / EBITDA | -15.11 |
| Interest Coverage | -2.82 |
| Return on Equity (ROE) | -2.61 |
| Return on Assets (ROA) | -0.90 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 0.43 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.24 |
Over the trailing twelve months, China Fineblanking Technology Co.,Ltd. has paid -8.60M in income taxes, reflecting an effective tax rate of 23.37.
| Income Tax | -8.60M |
| Effective Tax Rate | 23.37 |
China Fineblanking Technology Co.,Ltd.'s stock has declined approximately -26.34615% over the past 52 weeks. The 50-day moving average sits at 21.29, while the 200-day moving average is 24.37.
| Beta (5Y) | N/A |
| 52-Week Price Change | -26.34615% |
| 50-Day Moving Average | 21.29 |
| 200-Day Moving Average | 24.37 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, China Fineblanking Technology Co.,Ltd. generated 2.30B in revenue and converted that into -34.13M in net income, yielding earnings per share of -0.34. EBITDA reached -65.70M, while operating income came in at -65.70M.
| Revenue | 2.30B |
| Gross Profit | 282.29M |
| Operating Income | -65.70M |
| Pretax Income | -42.73M |
| Net Income | -34.13M |
| EBITDA | -65.70M |
| EBIT | -65.70M |
| Earnings Per Share (EPS) | -0.34 |
China Fineblanking Technology Co.,Ltd. holds 458.39M in cash and equivalents against 992.71M in total debt, resulting in a net debt position of 531.46M. Total book value stands at 1.38B, with working capital of 605.43M providing operational flexibility.
| Cash & Cash Equivalents | 458.39M |
| Total Debt | 992.71M |
| Net Debt | 531.46M |
| Equity (Book Value) | 1.38B |
| Book Value Per Share | 13.51 |
| Working Capital | 605.43M |
China Fineblanking Technology Co.,Ltd. produced 252.16M in operating cash flow over the past twelve months. After subtracting -50.14M in capital expenditures, free cash flow totaled 202.02M - equivalent to 1.99 per share.
| Operating Cash Flow | 252.16M |
| Capital Expenditures | -50.14M |
| Free Cash Flow | 202.02M |
| FCF Per Share | 1.99 |
China Fineblanking Technology Co.,Ltd. operates with a gross margin of 12.27, reflecting its pricing power and cost economics. The operating margin of -2.86 and net profit margin of -1.48 provide insight into operational efficiency.
| Gross Margin | 12.27 |
| Operating Margin | -2.86 |
| Pretax Margin | -1.86 |
| Profit Margin | -1.48 |
| EBITDA Margin | -2.86 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 7.34 |
| FCF Yield | 11.91 |
China Fineblanking Technology Co.,Ltd.'s most recent stock split took place on September 29, 2021 with a 50:51 split ratio.
| Last Split Date | 9/29/2021 |
| Split Ratio | 50:51 |
China Fineblanking Technology Co.,Ltd. posts an Altman Z-Score of 1.74, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.74 |